Institutional Cluster

MAZE

Maze Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed3mo ago
Institutional cluster: 3 buyers, 0 sellers (bullish)
Actionable Insight • Neutral

The cluster is entirely passive/index-driven (Vanguard, BlackRock, Morgan Stanley), likely reflecting index rebalancing or ETF inflows rather than a fundamental thesis. With MAZE's historical T+20 performance deeply negative and zero prior winning calls, this passive accumulation does not signal near-term upside. Monitor for active manager 13F filings or insider buying for a more reliable signal.

DirectionNeutral
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d
MAZE ▲ +8.80% at T+60d
NEUTRAL call ✓ call won +8.80% · α vs SPY +4.40% · entry $24.09 → $26.21
Entry anchored
Jun 10, 03:59 PM ET
via exchange tick
T+1d
-0.17%
call -0.17% · α -0.71%
$24.05
settled 4mo ago
T+5d
+3.11%
call +3.11% · α +2.68%
$24.84
settled 4mo ago
T+20d
+34.58%
call +34.58% · α +32.69%
$32.42
settled 3mo ago
T+60d
+8.80%
call +8.80% · α +4.40%
$26.21
settled 24d ago

Executive Summary

Three mega-passive institutional investors (Vanguard, BlackRock, Morgan Stanley) collectively doubled their positions in Maze Therapeutics during Q3 2025, adding $61.2M in new holdings to reach $74.3M total. This is a passive index-driven accumulation signal, not an active fundamental thesis, and follows a period of poor historical stock performance with zero winning calls at T+20.

Key Financial Metrics

Direction
accumulating
Buy Value
$74.3M
Sell Value
$0.00
Net Flow
$61.2M

Institutional Positions

Net institutional flow: $61.2M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
VanguardDOUBLED+218.1%$34.6M$29.5M
BlackRockDOUBLED+114.1%$34.1M$26.6M
Morgan StanleyDOUBLED+569.5%$5.5M$5.1M

Key Facts

  • 3 institutional buyers, 0 sellers in Q3 2025
  • Aggregate net buying: $61.2M (from $13.0M to $74.3M)
  • Vanguard doubled shares (+218.1%), BlackRock doubled (+114.1%), Morgan Stanley increased 569.5%
  • All three buyers are mega-passive/index funds — not active managers
  • Historical MAZE reports show 0% win rate at T+20 (n=6 settled), avg T+20 return -13.45%

Financial Impact

3 institutions accumulated $61.2M in new positions, bringing total disclosed holdings to $74.3M

institutional ownershipfloat

Risk Factors

  • Passive buying provides no fundamental validation — may be mechanically reversed in next rebalance
  • Historical MAZE reports show consistent negative T+20 returns regardless of filing type
  • No active manager participation suggests lack of conviction from informed capital

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MAZE-2025-Q3
19 reports for MAZE
Performance horizon
33% Hit rate 1 of 3 directional calls best @ T+5▲ +5.16%Jun 3, 2026
Filters
Rows
Reports for MAZE — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
Insider Cluster
NEUTRAL ★ 2/10
$26.37 $24.23▼ −8.12%▼ −7.00%—
Sep 4, 2026
27d ago
Insider Cluster
NEUTRAL ★ 3/10
$26.37 $24.23▼ −8.12%▼ −7.00%—
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$25.87 $24.60▼ −4.91%▼ −3.76%—
Sep 2, 2026
29d ago
144
NEUTRAL ★ 2/10
$25.87 $24.60▼ −4.91%▼ −3.76%—
Sep 1, 2026
4w ago
144
NEUTRAL ★ 3/10
$26.72 $24.82▼ −7.11%▼ −6.15%—
Aug 17, 2026
6w ago
3
NEUTRAL ★ 1/10
$29.13 $30.42▲ +4.43%▲ +4.63%—
Aug 11, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$27.53 $29.75▲ +8.06%▲ +8.51%—
Aug 7, 2026
8w ago
Institutional Cluster
BULLISH ★ 5/10
$28.65 $27.18▼ −5.13%▼ −5.53%—
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 3/10
$27.81 $27.53▼ −1.01%▼ −1.36%—
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$31.26 $32.42▲ +3.71%▲ +2.78%—
Showing 10 of 19

US Market Status

Market Open — Closes in 3h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026